Jieliang Chen, Yaming Li, Fritz Lai, Yang Wang, Kathrin Sutter, Ulf Dittmer, Jianyu Ye, Wenjing Zai, Min Liu, Fang Shen, Min Wu, Kongying Hu, Baocun Li, Mengji Lu, Xiaonan Zhang, Jiming Zhang, Jianhua Li, Qingfeng Chen, Zhenghong Yuan – 25 April 2020
Weiwei Hu, Shufang Zheng, Haixin Guo, Beiying Dai, Jiaping Ni, Yaohong Shi, Hanrui Bian, Lanxin Li, Yumeng Shen, Mo Wu, Zhoutong Tian, Guilai Liu, Md Amir Hossain, Hongbao Yang, Duowei Wang, Qin Zhang, Jun Yu, Lutz Birnbaumer, Jifeng Feng, Decai Yu, Yong Yang – 25 April 2020
Reinout L.P. Roscam Abbing, Folkert Kuipers, Coen C. Paulusma, Henkjan J. Verkade, Albert K. Groen, Ronald P.J. Oude Elferink, Stan F.J. Graaf – 25 April 2020
Surender Singh, Nipun Verma, Virendra Singh – 24 April 2020
Elizabeth S. Aby, Adam C. Winters, Jonathan Lin, Aileen Bui, Jenna Kawamoto, Matthew B. Goetz, Debika Bhattacharya, Joseph R. Pisegna, Folasade P. May, Arpan A. Patel, Jihane N. Benhammou – 24 April 2020 – Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death worldwide. Society guidelines recommend surveillance with abdominal ultrasound with or without serum alpha‐fetoprotein every 6 months for adults at increased risk of developing HCC. However, adherence is often suboptimal.
Jiezhong Chen, Luis Vitetta – 23 April 2020
Marcos F. Fondevila, Uxia Fernandez, Maria J. Gonzalez‐Rellan, Natalia Lima, Xabier Buque, Agueda Gonzalez‐Rodriguez, Cristina Alonso, Marta Iruarrizaga‐Lejarreta, Teresa C. Delgado, Marta Varela‐Rey, Ana Senra, Vera Garcia‐Outeiral, Eva Novoa, Cristina Iglesias, Begoña Porteiro, Daniel Beiroa, Cintia Folgueira, Marta Tojo, Jorge L. Torres, Lourdes Hernández‐Cosido, Óscar Blanco, Juan Pablo Arab, Francisco Barrera, Diana Guallar, Miguel Fidalgo, Miguel López, Carlos Dieguez, Miguel Marcos, Maria L. Martinez‐Chantar, Marco Arrese, Carmelo Garcia‐Monzon, Jose M.
Jonggi Choi, Chanyoung Jo, Young‐Suk Lim – 23 April 2020
Stephan Menne, Steffen Wildum, Guido Steiner, Manasa Suresh, Kyle Korolowicz, Maria Balarezo, Changsuek Yon, Marta Murreddu, Xupeng Hong, Bhaskar V. Kallakury, Robin Tucker, Song Yang, John A.T. Young, Hassan Javanbakht – 22 April 2020 – RG7834 is a small‐molecule inhibitor of hepatitis B virus (HBV) gene expression that significantly reduces the levels of hepatitis B surface antigen (HBsAg) and HBV DNA in a humanized liver HBV mouse model.